Antiphospholipid syndrome and nephrotic syndrome: are they related?

Detalhes bibliográficos
Autor(a) principal: Lança,Alice
Data de Publicação: 2015
Outros Autores: Escoli,Rachele, Ferrer,Francisco, Andrade,Sequeira
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000300011
Resumo: The antiphospholipid syndrome is a clinical entity that presents as arterial or venous thrombotic events in association with circulating phospholipid autoantibodies. Patients may display a constellation of neurologic, cardiovascular, obstetric and renal complications as a result of antibody-induced vessel injury. Kidneys are one of the most affected organs and its involvement often reflects the extension of the thrombotic process in its vasculature. However, in addition to the characteristic vascular findings of antiphospholipid nephropathy, an expanding spectrum of renal lesions has been reported. Primary glo- merulopathies may often overcome the clinical picture and present themselves as nephrotic syndrome with or without renal dysfunction. Here, we report a case of a 45-year old woman with antiphospholipid syndrome that presented to the emergency department with generalized oedema. After the initial workup nephrotic syndrome was assumed and a renal biopsy was performed. No detectable glomerular abnormalities other than sclerosis as a result of subcapsular ischaemia were seen. Immunofluorescence was negative for glomeruli deposits. The paucity of lesions in the non-sclerosed glomeruli pointed a primary podocytopathy as the most probable cause. The patient was started on corticosteroids with resultant complete remission in about 8 weeks. Nonetheless, during steroid tapering, the nephrotic syndrome relapsed and a higher dose was again needed for remission. However, the patient had to remain on low-dose corticosteroids for maintenance of nephrotic syndrome regression. Its sudden onset, together with the histological features and the good steroid response, made minimal change disease the most probable diagnosis. Yet, it remains unclear whether minimal change disease was related with antiphospholipid syndrome or was an unfortunate event.
id RCAP_7708223a3d124444e30ed11a5f955c32
oai_identifier_str oai:scielo:S0872-01692015000300011
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Antiphospholipid syndrome and nephrotic syndrome: are they related?Antiphospholipid syndromeminimal change diseasenephrotic syndromeThe antiphospholipid syndrome is a clinical entity that presents as arterial or venous thrombotic events in association with circulating phospholipid autoantibodies. Patients may display a constellation of neurologic, cardiovascular, obstetric and renal complications as a result of antibody-induced vessel injury. Kidneys are one of the most affected organs and its involvement often reflects the extension of the thrombotic process in its vasculature. However, in addition to the characteristic vascular findings of antiphospholipid nephropathy, an expanding spectrum of renal lesions has been reported. Primary glo- merulopathies may often overcome the clinical picture and present themselves as nephrotic syndrome with or without renal dysfunction. Here, we report a case of a 45-year old woman with antiphospholipid syndrome that presented to the emergency department with generalized oedema. After the initial workup nephrotic syndrome was assumed and a renal biopsy was performed. No detectable glomerular abnormalities other than sclerosis as a result of subcapsular ischaemia were seen. Immunofluorescence was negative for glomeruli deposits. The paucity of lesions in the non-sclerosed glomeruli pointed a primary podocytopathy as the most probable cause. The patient was started on corticosteroids with resultant complete remission in about 8 weeks. Nonetheless, during steroid tapering, the nephrotic syndrome relapsed and a higher dose was again needed for remission. However, the patient had to remain on low-dose corticosteroids for maintenance of nephrotic syndrome regression. Its sudden onset, together with the histological features and the good steroid response, made minimal change disease the most probable diagnosis. Yet, it remains unclear whether minimal change disease was related with antiphospholipid syndrome or was an unfortunate event.Sociedade Portuguesa de Nefrologia2015-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000300011Portuguese Journal of Nephrology & Hypertension v.29 n.3 2015reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000300011Lança,AliceEscoli,RacheleFerrer,FranciscoAndrade,Sequeirainfo:eu-repo/semantics/openAccess2024-02-06T17:04:50Zoai:scielo:S0872-01692015000300011Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:18:55.349497Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Antiphospholipid syndrome and nephrotic syndrome: are they related?
title Antiphospholipid syndrome and nephrotic syndrome: are they related?
spellingShingle Antiphospholipid syndrome and nephrotic syndrome: are they related?
Lança,Alice
Antiphospholipid syndrome
minimal change disease
nephrotic syndrome
title_short Antiphospholipid syndrome and nephrotic syndrome: are they related?
title_full Antiphospholipid syndrome and nephrotic syndrome: are they related?
title_fullStr Antiphospholipid syndrome and nephrotic syndrome: are they related?
title_full_unstemmed Antiphospholipid syndrome and nephrotic syndrome: are they related?
title_sort Antiphospholipid syndrome and nephrotic syndrome: are they related?
author Lança,Alice
author_facet Lança,Alice
Escoli,Rachele
Ferrer,Francisco
Andrade,Sequeira
author_role author
author2 Escoli,Rachele
Ferrer,Francisco
Andrade,Sequeira
author2_role author
author
author
dc.contributor.author.fl_str_mv Lança,Alice
Escoli,Rachele
Ferrer,Francisco
Andrade,Sequeira
dc.subject.por.fl_str_mv Antiphospholipid syndrome
minimal change disease
nephrotic syndrome
topic Antiphospholipid syndrome
minimal change disease
nephrotic syndrome
description The antiphospholipid syndrome is a clinical entity that presents as arterial or venous thrombotic events in association with circulating phospholipid autoantibodies. Patients may display a constellation of neurologic, cardiovascular, obstetric and renal complications as a result of antibody-induced vessel injury. Kidneys are one of the most affected organs and its involvement often reflects the extension of the thrombotic process in its vasculature. However, in addition to the characteristic vascular findings of antiphospholipid nephropathy, an expanding spectrum of renal lesions has been reported. Primary glo- merulopathies may often overcome the clinical picture and present themselves as nephrotic syndrome with or without renal dysfunction. Here, we report a case of a 45-year old woman with antiphospholipid syndrome that presented to the emergency department with generalized oedema. After the initial workup nephrotic syndrome was assumed and a renal biopsy was performed. No detectable glomerular abnormalities other than sclerosis as a result of subcapsular ischaemia were seen. Immunofluorescence was negative for glomeruli deposits. The paucity of lesions in the non-sclerosed glomeruli pointed a primary podocytopathy as the most probable cause. The patient was started on corticosteroids with resultant complete remission in about 8 weeks. Nonetheless, during steroid tapering, the nephrotic syndrome relapsed and a higher dose was again needed for remission. However, the patient had to remain on low-dose corticosteroids for maintenance of nephrotic syndrome regression. Its sudden onset, together with the histological features and the good steroid response, made minimal change disease the most probable diagnosis. Yet, it remains unclear whether minimal change disease was related with antiphospholipid syndrome or was an unfortunate event.
publishDate 2015
dc.date.none.fl_str_mv 2015-09-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000300011
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000300011
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000300011
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
dc.source.none.fl_str_mv Portuguese Journal of Nephrology & Hypertension v.29 n.3 2015
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137279113953280